Brief: Adamis Reports Agreement To Sell Portion Of US Compounding Business
04/08/2021 22:43
Aug 4 (Reuters) - Adamis Pharmaceuticals Corp ADMP.O :
* PRESS RELEASE - ADAMIS ANNOUNCES AGREEMENT TO SELL PORTION
OF US
COMPOUNDING BUSINESS
* ADAMIS PHARMACEUTICALS CORP - DEAL FOR ESTIMATED TO BE UP
TO $15
MILLION
Source text for Eikon: ID:nGNX9mP7pb
Further company coverage: ADMP.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on DMK Pharmaceuticals
See all newsBrief: Dmk Pharmaceuticals Corp Says Ebrahim Versi Resigned As Chairman
Brief: ZMI Pharma Finalized Acquisition Of All Strategic Assets Necessary To Manufacture Zimhi From Dmk Pharma
Brief: DMK Pharmaceuticals Files For Chapter 11 Bankruptcy In The U.S. - Court Filing
Brief: Dmk Pharmaceuticals Regains Full Rights To Commercialize Zimhi
Brief: DMK Pharmaceuticals Regains Full Rights From US Worldmeds For Symjepi And Provides Corporate Update